# Celecoxib

## Celebrex 200mg

| TAH Drug Code      | [OCEL2](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OCEL2)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Relief of symptoms and signs of osteoarthritis， relief of symptoms and signs of adult rheumatoid arthritis， relief of acute pain in adults and treatment of primary dysmenorrhea， relief of symptoms and signs of ankylosing spondylitis.                                                                                                                                                                                                                                                                                                                                                      |
| Dosing             | Osteoarthritis: 200mg QD， or 100mg BID Rheumatoid arthritis: 100-200mg BID Ankylosing Spondylitis (AS):200mg/day in single (once a day) or divided (twice a day) dose. If it doesn't work after six weeks， try 400 mg/day. If there is no effect after another 6 weeks， there will be no therapeutic response， and other treatments should be considered. Relieve acute pain and treat primary dysmenorrhea: initial dose: 400mg， then 200 mg twice a day when needed.                                                                                                                       |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | ‧ Patients known to be allergic to celecoxib or any component of the drug (such as experiencing systemic allergic reactions or severe skin reactions). ‧ Patients who have experienced asthma， urticaria， or other allergic reactions after taking aspirin or other NSAIDs. Such patients have been reported to experience severe， sometimes fatal， systemic allergic reactions to NSAIDs. ‧ This drug should not be used within 14 days after coronary artery bypass graft (CABG) surgery. ‧ Patients who have had allergic reactions to sulfonamides.                                       |
| Adverse Effects    | Abdominal pain， diarrhea， dyspepsia， flatulence， peripheral edema， dizziness， pharyngitis， rhinitis， sinusitis， upper respiratory tract infection， rash. Cardiovascular: Hypertension (arthritis， 2.4% ; familial adenomatous polyposis， 12.5% ) Gastrointestinal: Diarrhea (arthritis， 5.6%; familial adenomatous polyposis， 10.5%; juvenile rheumatoid arthritis， 4% to 5% )， Nausea (arthritis， 3.5%; familial adenomatous polyposis， 6.8%; juvenile rheumatoid arthritis， 4% to 7% ) Neurologic: Headache (arthritis， 15.8%; juvenile rheumatoid arthritis， 10% to 13% ) |
| Pregnancy          | Human Data Suggest Risk in 1st and 3rd Trimesters                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/celecoxib-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

